Cargando…
High prevalence of the MLH1 V384D germline mutation in patients with HER2-positive luminal B breast cancer
HER2-positive luminal B breast cancer (BC), a subset of the luminal B subtype, is ER-positive and HER2-positive BC which is approximately 10% of all BC. However, HER2-positive luminal B BC has received less attention and is less represented in previous molecular analyses than other subtypes. Hence,...
Autores principales: | Lee, Seung Eun, Lee, Hye Seung, Kim, Kyoung-Yeon, Park, Jung-Hoon, Roh, Hanseong, Park, Ha Young, Kim, Wan-Seop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662670/ https://www.ncbi.nlm.nih.gov/pubmed/31358837 http://dx.doi.org/10.1038/s41598-019-47439-3 |
Ejemplares similares
-
Isolated MLH1 Loss by Immunohistochemistry Because of Benign Germline MLH1 Polymorphisms
por: Bosch, Dustin E., et al.
Publicado: (2022) -
A novel germline mutation in hMLH1 in three Korean women with endometrial cancer in a family of Lynch syndrome: case report and literature review
por: Jung, Youn-Joon, et al.
Publicado: (2021) -
Differences in clinical outcomes between HER2-negative and HER2-positive luminal B breast cancer
por: Kang, Byeongju, et al.
Publicado: (2023) -
Characterization of somatic mutations of colorectal tumor in a patient with concurrent APC and MLH1 germline mutations
por: Cheng, Yunsheng, et al.
Publicado: (2023) -
Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review
por: Yokoyama, Takanori, et al.
Publicado: (2018)